Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
Scientific Reports|February 11, 2018
2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophyZaid H Maayah, Jody Levasseur, Ramanaguru Siva Piragasam, et al.
Molecular and Cellular Biochemistry|July 12, 2023
16R-HETE and 16S-HETE alter human cytochrome P450 1B1 enzyme activity probably through an allosteric mechanismRahmat Hidayat, Sherif M Shoieb, Farag E S Mosa, et al.
Toxicology and Applied Pharmacology|February 21, 2015
Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathwayZaid H Maayah, Hazem Ghebeh, Abdulqader A Alhaider, et al.
Toxicology Letters|May 1, 2025
The induction of quinone oxidoreductases NQO1 and NQO2 by clozapine: Potential implications for clozapine-induced agranulocytosisMd Harunur Rashid, Dinesh Babu, Newton H Tran, et al.
Cardiovascular Toxicology|December 3, 2017
The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated CardiotoxicityZaid H Maayah, Ghada Abdelhamid, Osama H Elshenawy, et al.
Drug Delivery and Translational Research|May 3, 2017
Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivativeSamaa Alrushaid, Yunqi Zhao, Casey L Sayre, et al.
Toxicology and Applied Pharmacology|March 29, 2026
Effects of music on hepatic cytochrome P450 1A enzymes in Sprague Dawley ratsAli H Shalaby, Jinal Adhiya, Ala''a R Al-Dajani, et al.
BMC Cancer|August 14, 2020
Breast cancer diagnosis is associated with relative left ventricular hypertrophy and elevated endothelin-1 signalingZaid H Maayah, Shingo Takahara, Abrar S Alam, et al.
Drug Delivery and Translational Research|August 4, 2018
Correction to: Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivativeSamaa Alrushaid, Yunqi Zhao, Casey L Sayre, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|April 28, 2018
Pharmaceutical Characterization of MyoNovin, a Novel Skeletal Muscle Regenerator: in silico, in vitro and in vivo StudiesSamaa Alrushaid, Neal M Davies, Judy E Anderson, et al.
Pageof 21